Recombinant activated factor VII (rFVIIa) is a powerful prohaemostatic agent that theoretically predisposes to thrombosis after peripheral vascular surgery. We report the use of rFVIIa to reduce bleeding in a patient after axillofemoral bypass grafting for ruptured aorto-iliac pseudoaneurysm. Despite the increased risk of thrombosis, the patient made an uneventful recovery with preserved graft patency. The favourable result suggests that rFVIIa should be considered even in vascular surgical patients, if the risks of continued bleeding outweigh those of thrombosis. Better risk estimation is only possible if reports of rFVIIa use in vascular patients continue to appear and through controlled trials.
HednerU.Recombinant factor VIIa (NovoSeven) as a hemostatic agent.Dis-A-Month2003; 49: 39–48.
2.
HathcockJ.Vascular biology—The role of tissue factor.Sem Hematol2004; 41 Suppl 1: 30–34.
3.
MakinA.J., ChungN.A., SilvermanS.H., LipG.Y.Vascular endothelial growth factor and tissue factor in patients with established peripheral artery disease: a link between angiogenesis and thrombogenesis?Clin Sci2003; 104: 397–404.
4.
AbshireT., KenetG.Recombinant factor VIIa: a review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitors.J Thromb Haemost2004; 2: 899–909.
5.
RobertsH.R.Recombinant factor VIIa: how safe is the stuff?Can J Anesth2005; 521: 8–11.
6.
TanakaK.A., WalyA.A., CooperW.A., LevyJ.H.Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant factor VIIa (NovoSeven).Anesthesiology2003; 98: 1513–1515.
7.
NaikV.N., MazerC.D., LatterD.A.Successful treatment using recombinant factor VIIa for severe bleeding post cardiopulmonary bypass.Can J Anesth2003; 50: 599–602.
8.
EikelboomJ.W., BirdR., BlytheD.Recombinant activated factor VII for the treatment of life-threatening hemorrhage.Blood Coag Fibrinol2003; 14: 713–717.
9.
TobiasJ.D., BerkenboschJ.W., RussoP.Recombinant factor VIIa to treat bleeding after cardiac surgery in an infant.Ped Crit Care Med2003; 4: 49–51.
10.
Al DouriM.The use of recombinant factor VIIa in controlling surgical bleeding in non-haemophiliac patients.Pathophysiol Haemost Thromb2002; 32(suppl 1): 41–46.
11.
StratmannG., RussellI.A., MerrickS.H.Use of recombinant factor VIIa as a rescue treatment for intractable bleeding following repeat aortic arch repair.Ann Thorac Surg2003; 76: 2094–2097.
12.
MaimonM., BernsteinT., KenetG., KapelushnikJ.Recombinant factor VIIa for treatment of a child with severe factor VII deficiency and coarctation of the aorta.J Ped Hematol Oncol2003; 25: 591.
13.
WahlgrenC.M., SwedenborgJ.The use of recombinant activated factor VII to control bleeding during repair of a supra-renal abdominal aortic aneurysm.Eur J Vasc Endovasc Surg2003; 26: 221–222.
14.
LeviM., JongeE., PollT.New strategies for disseminated intravascular coagulation based on current understanding of the pathophysiology.Ann Med2003; 35: 1–9.
15.
AsakuraH., OntachiY., MizutaniT.An enhanced fibrinolysis prevents the development of multiple organ failure in disseminated intravascular coagulation in spite of much activation of blood coagulation.Crit Care Med2001; 29: 1164–1168.
16.
HednerU., ErhardtsenE.Potential role for rFVIIa in transfusion medicine.Transfusion2002; 42: 114–124.
17.
GoodnoughL.T., LublinD.M., ZhangL.Transfusion medicine service policies for recombinant factor VIIa administration.Transfusion2004; 44: 1325–1331.
18.
MartinowitzU., MichaelsonM.Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: a report by the Israeli Multidisciplinary rFVIIa Task Force.J Thromb Haemost2005; 3: 640–648.
19.
BrownJ.L., VarmaS., Morgan-HughesN.J., RoccoG.Thrombosis related to emergency factor VIIa treatment.Anaesthesia2003; 58: 1245.
20.
Van der PlankenM.G., SchroyensW., VertessenF.Distal deep venous thrombosis in a hemophilia A patient with severe infectious disease, 18 days after recombinant activated factor transfusion.Blood Coagul Fibrinolysis2002; 13: 367–370.
21.
PeerlinckK., VermylenJ.Acute myocardial infarction following administration of recombinant activated factor VII in a patient with haemophilia A and inhibitor.Thromb Haemost1999; 82: 1775–1776.
22.
SiegelL.J., GerigkL., TuettenbergJ.Cerebral Sinus Thrombosis in a Trauma Patient after Recombinant Activated Factor VII Infusion.Anesthesiology2004; 100: 441–443.
23.
PaveseP., BonadonaA., BeaubienJ.FVIIa corrects the coagulopathy of fulminant hepatic failure but may be associated with thrombosis: a report of four cases.Can J Anesth2005; 52: 26–29.
